Overview
Compare with Walgreens Boots Alliance , 111, Inc. or Guardian Pharmacy Services, Inc. , or pick any stock .
Ticker RAD on NYSE1 Industry retail1 Headquarters Philadelphia1 Website www.riteaid.com Legal form public company1 Incorporated in DE5 Business address 1200 Intrepid Avenue, 2Nd Floor, Philadelphia, Pa 191125 Filer category Accelerated filer5
See how the biggest companies compare on our leaderboards
Photo: TaurusEmerald, CC BY-SA 4.0 , via Wikimedia Commons 6
Rite Aid Corporation was an American drugstore chain based in Philadelphia. Founded in 1962 in Scranton, Pennsylvania, at its peak it operated more than 5,000 stores. By May 2025, it operated only 1,200 stores across 15 U.S. states and was the seventh-largest pharmacy in the U.S. when taking into account big box chains.3
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023 -1.9% Revenue growth, 20237 Where the money goes Where each dollar of revenue went, fiscal 2023 Cost of revenue Selling, general and admin
Cost of revenue 79¢ $19.3B Selling, general and admin 20¢ $4.9B Interest 1¢ $224.4M Income tax 0¢ $6.5M Out of $24.1B in revenue.7 The company lost money this year.
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue8 9 7 $24.1B in 2023+5% since 2017 0 $10.0B $20.0B $30.0B 2017: $22.9B $22.9B 2017 2018: $21.5B $21.5B 2018 −6% 2019: $21.6B $21.6B 2019 +1% 2020: $21.9B $21.9B 2020 +1% 2021: $24.0B $24.0B 2021 +10% 2022: $24.6B $24.6B 2022 +2% 2023: $24.1B $24.1B 2023 −2% Gross profit8 10 11 9 7 $4.8B in 2023−5% since 2017 0 $2.0B $4.0B $6.0B 2017: $5.1B $5.1B 2017 2018: $4.8B $4.8B 2018 −6% 2019: $4.7B $4.7B 2019 −2% 2020: $4.7B $4.7B 2020 +1% 2021: $4.7B $4.7B 2021 −0% 2022: $5.1B $5.1B 2022 +9% 2023: $4.8B $4.8B 2023 −6% Net income8 10 11 9 7 -$719.2M in 2023-$1.0B -$500.0M 0 $500.0M $1.0B 2017: $4.1M $4.1M 2017 2018: $943.5M $943.5M 2018 +23178% 2019: -$422.2M -$422.2M 2019 2020: -$452.2M -$452.2M 2020 +7% 2021: -$90.2M -$90.2M 2021 −80% 2022: -$522.4M -$522.4M 2022 +479% 2023: -$719.2M -$719.2M 2023 +38%
Revenue12 13 $5.6B in Q2 FY2023−0% since Q1 FY2023 0 $2.0B $4.0B $6.0B Q1 FY2023: $5.7B $5.7B Q1 FY2023 Q2 FY2023: $5.6B $5.6B Q2 FY2023 −0% Gross profit12 13 $1.1B in Q2 FY2023−7% since Q1 FY2023 0 $500.0M $1.0B $1.5B Q1 FY2023: $1.2B $1.2B Q1 FY2023 Q2 FY2023: $1.1B $1.1B Q2 FY2023 −7% Net income12 13 -$1.0B in Q2 FY2023+230% since Q1 FY2023 -$1.5B -$1.0B -$500.0M 0 Q1 FY2023: -$306.4M -$306.4M Q1 FY2023 Q2 FY2023: -$306.4M -$306.4M Q2 FY2023 +0% Q2 FY2023: -$1.0B -$1.0B Q2 FY2023 +230%
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Revenue $22.9B8 $21.5B8 $21.6B8 $21.9B9 $24.0B7 $24.6B7 $24.1B7 Cost of revenue $17.9B8 $16.7B10 $17.0B11 $17.2B9 $19.3B7 $19.5B7 $19.3B7 Gross profit $5.1B8 $4.8B10 $4.7B11 $4.7B9 $4.7B7 $5.1B7 $4.8B7 Selling, general and admin $4.8B8 $4.7B10 $4.6B11 $4.6B9 $4.7B7 $5.0B7 $4.9B7 Interest $200.1M8 $202.8M10 $227.7M11 $229.7M9 $201.4M7 $191.6M7 $224.4M7 Income tax $44.4M8 $306.0M10 $77.5M11 $387.6M9 -$20.2M7 -$3.8M7 -$6.5M7 Net income $4.1M8 $943.5M10 -$422.2M11 -$452.2M9 -$90.2M7 -$522.4M7 -$719.2M7 Earnings per share $0.088 $17.988 -$7.998 -$8.509 -$1.687 -$9.667 -$13.157 Earnings per share (diluted) $0.088 $17.988 -$7.998 -$8.509 -$1.687 -$9.667 -$13.157
Total assets14 10 11 9 7 $7.5B in 2023−35% since 2017 0 $5.0B $10.0B $15.0B 2017: $11.6B $11.6B 2017 2018: $9.0B $9.0B 2018 −23% 2019: $7.6B $7.6B 2019 −15% 2020: $9.5B $9.5B 2020 +25% 2021: $9.3B $9.3B 2021 −1% 2022: $8.5B $8.5B 2022 −9% 2023: $7.5B $7.5B 2023 −12% Total liabilities14 8 10 11 7 $8.1B in 2023−26% since 2017 0 $5.0B $10.0B $15.0B 2017: $11.0B $11.0B 2017 2018: $7.4B $7.4B 2018 −33% 2019: $6.4B $6.4B 2019 −13% 2020: $8.8B $8.8B 2020 +37% 2021: $8.7B $8.7B 2021 −1% 2022: $8.4B $8.4B 2022 −4% 2023: $8.1B $8.1B 2023 −3% Shareholders’ equity10 9 7 -$594.2M in 2023-$1.0B 0 $1.0B $2.0B 2017: $614.1M $614.1M 2017 2018: $1.6B $1.6B 2018 +159% 2019: $1.2B $1.2B 2019 −25% 2020: $674.5M $674.5M 2020 −43% 2021: $615.8M $615.8M 2021 −9% 2022: $115.8M $115.8M 2022 −81% 2023: -$594.2M -$594.2M 2023 Cash10 11 9 7 $157.2M in 2023−36% since 2017 0 $200.0M $400.0M $600.0M 2017: $245.4M $245.4M 2017 2018: $447.3M $447.3M 2018 +82% 2019: $144.4M $144.4M 2019 −68% 2020: $218.2M $218.2M 2020 +51% 2021: $160.9M $160.9M 2021 −26% 2022: $39.7M $39.7M 2022 −75% 2023: $157.2M $157.2M 2023 +296% Long-term debt14 8 10 11 9 7 $2.9B in 2023−10% since 2017 0 $1.0B $2.0B $3.0B $4.0B 2017: $3.2B $3.2B 2017 2018: $3.3B $3.3B 2018 +3% 2019: $3.5B $3.5B 2019 +3% 2020: $3.1B $3.1B 2020 −11% 2021: $3.1B $3.1B 2021 −0% 2022: $2.7B $2.7B 2022 −11% 2023: $2.9B $2.9B 2023 +7%
Total assets13 12 $7.1B in Q2 FY2023−5% since Q2 FY2023 0 $2.0B $4.0B $6.0B $8.0B Q2 FY2023: $7.5B $7.5B Q2 FY2023 Q1 FY2023: $7.7B $7.7B Q1 FY2023 +2% Q2 FY2023: $7.1B $7.1B Q2 FY2023 −7% Total liabilities13 12 $9.0B in Q2 FY2023+11% since Q2 FY2023 0 $2.5B $5.0B $7.5B $10.0B Q2 FY2023: $8.1B $8.1B Q2 FY2023 Q1 FY2023: $8.6B $8.6B Q1 FY2023 +5% Q2 FY2023: $9.0B $9.0B Q2 FY2023 +6% Shareholders’ equity13 12 -$1.9B in Q2 FY2023+221% since Q2 FY2023 -$2.0B -$1.5B -$1.0B -$500.0M 0 Q2 FY2023: -$594.2M -$594.2M Q2 FY2023 Q1 FY2023: -$899.6M -$899.6M Q1 FY2023 +51% Q2 FY2023: -$899.6M -$899.6M Q2 FY2023 +0% Q2 FY2023: -$1.9B -$1.9B Q2 FY2023 +112% Cash13 12 $92.9M in Q2 FY2023−41% since Q2 FY2023 0 $50.0M $100.0M $150.0M $200.0M Q2 FY2023: $157.2M $157.2M Q2 FY2023 Q1 FY2023: $135.5M $135.5M Q1 FY2023 −14% Q2 FY2023: $92.9M $92.9M Q2 FY2023 −31% Long-term debt13 12 $3.3B in Q1 FY2023+14% since Q2 FY2023 0 $1.0B $2.0B $3.0B $4.0B Q2 FY2023: $2.9B $2.9B Q2 FY2023 Q1 FY2023: $3.3B $3.3B Q1 FY2023 +14%
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Cash $245.4M10 $447.3M10 $144.4M10 $218.2M11 $160.9M9 $39.7M7 $157.2M7 Current assets $5.1B14 $4.7B8 $4.1B10 $3.7B11 $3.6B9 $3.4B7 $3.3B7 Total assets $11.6B14 $9.0B10 $7.6B10 $9.5B11 $9.3B9 $8.5B7 $7.5B7 Current liabilities $3.0B14 $3.5B8 $2.4B10 $2.8B11 $2.6B7 $2.9B7 $2.7B7 Long-term debt $3.2B14 $3.3B8 $3.5B10 $3.1B11 $3.1B9 $2.7B7 $2.9B7 Total liabilities $11.0B14 $7.4B8 $6.4B10 $8.8B11 $8.7B7 $8.4B7 $8.1B7 Shareholders’ equity $614.1M10 $1.6B10 $1.2B9 $674.5M7 $615.8M7 $115.8M7 -$594.2M7 Shares outstanding 1.1B shares15 1.1B shares14 53.9M shares8 54.7M shares10 55.1M shares11 55.6M shares9 56.4M shares16
Capital spending8 10 11 9 7 $215.3M in 2023−15% since 2017 0 $100.0M $200.0M $300.0M 2017: $254.1M $254.1M 2017 2018: $185.9M $185.9M 2018 −27% 2019: $196.8M $196.8M 2019 +6% 2020: $171.7M $171.7M 2020 −13% 2021: $195.1M $195.1M 2021 +14% 2022: $194.1M $194.1M 2022 −1% 2023: $215.3M $215.3M 2023 +11%
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Fiscal year 2017 2018 2019 2020 2021 2022 2023 Capital spending $254.1M8 $185.9M10 $196.8M11 $171.7M9 $195.1M7 $194.1M7 $215.3M7
Compare Rite Aid with another company
The story
Founded by Alex Grass in 1962.1
Leadership
Who has led Rite Aid, and when. Pick a name to see everywhere that person has worked.
Board members and other officers (1)
Products and brands
Listed on Wikidata.1
Subsidiaries and ownership
Subsidiaries
From Wikidata.1
Acquisitions
Apr 2014 Acquired RediClinic1
Former names
RITE AID CORP Sep 9, 1994 to Sep 5, 20245
Timeline
Jan 2, 1990 Went public Listed on NYSE1 1962 Founded Founded1
Recent filings
Sep 9, 2024 3 Jul 29, 2024 8-K Jul 25, 2024 10-K/A Jul 25, 2024 10-Q/A Jul 25, 2024 10-Q/A Feb 6, 2024 8-K Dec 27, 2023 8-K Nov 1, 2023 8-K Oct 19, 2023 8-K Oct 18, 2023 10-Q Oct 16, 2023 8-K Oct 16, 2023 8-K/A Oct 4, 2023 8-K Aug 24, 2023 8-K Aug 24, 2023 3 FORM 3 SUBMISSION
Every filing from the last three years, summarized . The full record is on SEC EDGAR.2